Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents

Journal of Leukocyte Biology

Volumn 75, Issue 4, 2004, Pages 624-630

  Rose, Bettina ^a   Herder, Christian ^a   Löffler, Heike ^a   Kolb, Hubert ^a   Martin, Stephan ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Adaptive immunity; Immune mediators; Immunomodulation; LPS

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYDROCORTISONE; IMMUNOMODULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; MIXED LYMPHOCYTE CULTURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; AUTOIMMUNE DISEASES; CELL CULTURE TECHNIQUES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HUMANS; HYDROCORTISONE; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IMMUNOASSAY; INFLAMMATION; INTERFERON TYPE II; INTERLEUKINS; LIPOPOLYSACCHARIDES; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTES;

EID: 1642547107     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1003454     Document Type: Article

References (38)

1. Beckman, J. A., Creager, M. A., Libby, P. (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287, 2570-2581.
2. Zimmet, P. Z., McCarty, D. J., de Courten, M. P. (1997) The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J. Diabetes Complications 11, 60-68.
3. Koenig, W., Sund, M., Frohlich, M., Fischer, H. G., Lowel, H., Doring, A., Hutchinson, W. L., Pepys, M. B. (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99, 237-242.
4. Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E., Ridker, P. M. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334.
5. Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., Heiss, G. (1999) Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353, 1649-1652.
6. Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger Jr., W. H., Heimovitz, H., Cohen, H. J., Wallace, R. (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106, 506-512.
7. Phillips, M. I., Kagiyama, S. (2002) Angiotensin II as a pro-inflammatory mediator. Curr. Opin. Investig. Drugs 3, 569-577.
8. van de Ree, M. A., Huisman, M. V., Princen, H. M., Meinders, A. E., Kluft, C. (2003) Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 166, 129-135.
9. Kinlay, S., Selwyn, A. P. (2003) Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am. J. Cardiol. 91, 9B-13B.
10. Kruse, N., Pette, M., Toyka, K., Rieckmann, P. (1997) Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J. Immunol. Methods 210, 195-203.
11. Perussia, B., Mangoni, L., Engers, H. D., Trinchieri, G. (1980) Interferon production by human and murine lymphocytes in response to alloantigens. J. Immunol. 125, 1589-1595.
12. Novelli, F., Giovarelli, M., Reber-Liske, R., Virgallita, G., Garotta, G., Forni, G. (1991) Blockade of physiologically secreted IFN-γ inhibits human T lymphocyte and natural killer cell activation. J. Immunol. 147, 1445-1452.
13. Cantell, K., Koskimies, S., Hirvonen, S. (1990) Production of interferon in mixed leukocyte cultures from two individuals. J. Interferon Res. 10, 331-335.
14. Harmon, W. E., Parkman, R., Lavin, P. T., Grupe, W. E., Ingelfinger, J. R., Yunis, E. J., Levey, R. H. (1982) Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation. J. Immunol. 129, 1573-1577.
15. Cartwright, N. H., Demaine, A. G., Hurlock, N. J., McGonigle, R. J., Rowe, P. A., Shaw, J. F., Szydlo, R. M., Kaminski, E. R. (2000) Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching. Transpl. Immunol. 8, 109-114.
16. Burke, G. W., Allouch, M., Cirocco, R., Markou, M., Gomez, C., Contreras, N., Esquenazi, V., Roth, D., Nery, J., Miller, J. (1994) Rejection in HLA-identical living related donor kidney transplants: lack of predictive immunologic parameters. Transplantation 57, 750-751.
17. Netea, M. G., van Deuren, M., Kullberg, B. J., Cavaillon, J. M., Van der Meer, J. W. (2002) Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol. 23, 135-139.
18. Ulevitch, R. J., Tobias, P. S. (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13, 437-457.
19. Romagnani, S. (1997) The Th1/Th2 paradigm. Immunol. Today 18, 263-266.
20. Sai, P., Rivereau, A. S. (1996) Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysaccharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diabetes Metab. 22, 341-348.
21. Balasa, B., Van Gunst, K., Sarvetnick, N. (2000) The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoir of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes. Clin. Immunol. 95, 93-98.
22. Tian, J., Zekzer, D., Hanssen, L., Lu, Y., Olcott, A., Kaufman, D. L. (2001) Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167, 1081-1089.
23. Scott, F. W., Roswell, P., Wang, G. S., Burghardt, K., Kolb, H., Flohé, S. (2002) Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. Diabetes 51, 73-78.
24. Spear, G. T., Marshall, P., Teodorescu, M. (1986) Increase in proliferation and cytotoxic cell development in human mixed lymphocyte cultures in the presence of very low concentrations of LPS: role of IL-1 and prostaglandin E2. Clin. Immunol. Immunopathol. 38, 32-46.
25. Spear, G. T., Teodorescu, M. (1984) Enhancement of human MLR by very low concentrations of lipopolysaccharide and blocking of this enhancement by polymyxin B. J. Immunol. Methods 73, 321-327.
26. Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
27. Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., Fukuda, S., Kurimoto, M. (1996) Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26, 1647-1651.
28. Okamura, H., Kashiwamura, S., Tsutsui, H., Yoshimoto, T., Nakanishi, K. (1998) Regulation of interferon-γ production by IL-12 and IL-18. Curr. Opin. Immunol. 10, 259-264.
29. Kohka, H., Iwagaki, H., Yoshino, T., Kobashi, K., Urushihara, N., Yagi, T., Tanimoto, T., Kurimoto, M., Akagi, T., Tanaka, N. (1999) Involvement of interleukin-18 (IL-18) in mixed lymphocyte reactions (MLR). J. Interferon Cytokine Res. 19, 1053-1057.
30. Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., Demengeot, J. (2003) Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197, 403-411.
31. Carson, W. E., Ross, M. E., Baiocchi, R. A., Marien, M. J., Boiani, N., Grabstein, K., Caligiuri, M. A. (1995) Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96, 2578-2582.
32. Danzer, S. G., Kirchner, H., Rink, L. (1994) Cytokine interactions in human mixed lymphocyte culture. Transplantation 57, 1638-1642.
33. Ruppert, J., Friedrichs, D., Xu, H., Peters, J. H. (1991) IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency. Immunobiology 182, 449-464.
34. Snijders, A., Hilkens, C. M., van der Pouw Kraan, T. C., Engel, M., Aarden, L. A., Kapsenberg, M. L. (1996) Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156, 1207-1212.
35. Gollob, J. A., Kawasaki, H., Ritz, J. (1997) Interferon-γ and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression, Eur. J. Immunol. 27, 647-652.
36. Hill, G. R., Teshima, T., Gerbitz, A., Pan, L., Cooke, K. R., Brinson, Y. S., Crawford, J. M., Ferrara, J. L. (1999) Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia. J. Clin. Invest. 104, 459-467.
37. Yabe, M., Yabe, H., Hattori, K., Shimizu, T., Matsumoto, M., Morimoto, T., Yasuda, Y., Inoue, H., Kato, S., Nishimura, T. (1999) Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients. Bone Marrow Transplant. 24, 29-34.
38. Price, K. S., Nestel, F. P., Lapp, W. S. (1997) Progressive accumulation of bacterial lipopolysaccharide in vivo during murine acute graft-versus-host disease. Scand. J. Immunol. 45, 294-300.